Literature DB >> 15901649

Mitochondrial changes in skeletal muscle in amyotrophic lateral sclerosis and other neurogenic atrophies.

Anna Krasnianski1, Marcus Deschauer, Stephan Neudecker, Frank N Gellerich, Tobias Müller, Benedikt G Schoser, Michael Krasnianski, Stephan Zierz.   

Abstract

Previous findings suggested specific mitochondrial dysfunction in skeletal muscle of patients with amyotrophic lateral sclerosis (ALS). To answer the question of whether the dysfunction is specific, we investigated the histochemical distribution of mitochondrial marker activities, the ratio of mitochondrial (mt) versus nuclear (n) DNA, and the activities of citrate synthase (CS) and respiratory chain enzymes in muscle biopsies of 24 patients with sporadic ALS. The data were compared with those in 23 patients with other neurogenic atrophies (NAs), and 21 healthy controls. Muscle histology revealed similar signs of focally diminished mitochondrial oxidation activity in muscle fibres in both diseased groups. There was only minimal decline of mt/nDNA ratios in ALS and NA patients in comparison with healthy controls. The specific activities of mitochondrial markers CS and succinate dehydrogenase were significantly increased in both ALS and NA patients. The specific activities of respiratory chain enzymes were not significantly different in all three groups. It is concluded that the histochemical, biochemical and molecular mitochondrial changes in muscle are not specific for ALS, but accompany other NAs as well.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15901649     DOI: 10.1093/brain/awh540

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  34 in total

1.  Investigation of the mitochondrial genome in patients with atypical motor neuron disease.

Authors:  Catherine Phoenix; Geoffrey A Taylor; Judith Hartley; Hannah Nixon; Paul G Ince; Pamela J Shaw; Douglass M Turnbull; Robert W Taylor
Journal:  J Neurol       Date:  2007-03-31       Impact factor: 4.849

2.  Quantity and activation of myofiber-associated satellite cells in a mouse model of amyotrophic lateral sclerosis.

Authors:  Raquel Manzano; Janne M Toivonen; Ana Cristina Calvo; Sara Oliván; Pilar Zaragoza; Maria Jesús Muñoz; Didier Montarras; Rosario Osta
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

3.  Strictly monitored exercise programs reduce motor deterioration in ALS: preliminary results of a randomized controlled trial.

Authors:  Christian Lunetta; Andrea Lizio; Valeria A Sansone; Nadia Maria Cellotto; Eleonora Maestri; Massimo Bettinelli; Valentina Gatti; Mario Giovanni Melazzini; Giovanni Meola; Massimo Corbo
Journal:  J Neurol       Date:  2016-01       Impact factor: 4.849

4.  Amyotrophic Lateral Sclerosis Associated with Statin Use: A Disproportionality Analysis of the FDA's Adverse Event Reporting System.

Authors:  Beatrice A Golomb; Abril Verden; Alexis K Messner; Hayley J Koslik; Keith B Hoffman
Journal:  Drug Saf       Date:  2018-04       Impact factor: 5.606

5.  Measures of bulbar and spinal motor function, muscle innervation, and mitochondrial function in ALS rats.

Authors:  Susan E Smittkamp; Heather N Spalding; Jordan W Brown; Anisha A Gupte; Jie Chen; Hiroshi Nishimune; Paige C Geiger; John A Stanford
Journal:  Behav Brain Res       Date:  2010-03-06       Impact factor: 3.332

6.  Peroxisome proliferator-activated receptor γ coactivator 1 (PGC-1)- and estrogen-related receptor (ERR)-induced regulator in muscle 1 (Perm1) is a tissue-specific regulator of oxidative capacity in skeletal muscle cells.

Authors:  Yoshitake Cho; Bethany C Hazen; Aaron P Russell; Anastasia Kralli
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

Review 7.  Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis.

Authors:  Emanuele D'Amico; Pam Factor-Litvak; Regina M Santella; Hiroshi Mitsumoto
Journal:  Free Radic Biol Med       Date:  2013-06-21       Impact factor: 7.376

8.  Ca2+-activated K+ channels modulate microglia affecting motor neuron survival in hSOD1G93A mice.

Authors:  Germana Cocozza; Maria Amalia di Castro; Laura Carbonari; Alfonso Grimaldi; Fabrizio Antonangeli; Stefano Garofalo; Alessandra Porzia; Michele Madonna; Fabrizio Mainiero; Angela Santoni; Francesca Grassi; Heike Wulff; Giuseppina D'Alessandro; Cristina Limatola
Journal:  Brain Behav Immun       Date:  2018-07-03       Impact factor: 7.217

Review 9.  Advances in cellular models to explore the pathophysiology of amyotrophic lateral sclerosis.

Authors:  C Veyrat-Durebex; P Corcia; A Dangoumau; F Laumonnier; E Piver; P H Gordon; C R Andres; P Vourc'h; H Blasco
Journal:  Mol Neurobiol       Date:  2013-11-07       Impact factor: 5.590

Review 10.  Amyotrophic lateral sclerosis.

Authors:  Lokesh C Wijesekera; P Nigel Leigh
Journal:  Orphanet J Rare Dis       Date:  2009-02-03       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.